Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis 2019-10-15 05:58
Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs 2019-10-15 04:11
WONTECH Receives FDA Clearance for 'HairBoom Air' 2019-10-14 16:47
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business 2019-10-14 12:51
ZEISS showcases next-level eye care digitalization at AAO 2019 2019-10-12 22:00
CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership 2019-10-11 18:00
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
Bayer G4A Partners With Wellthy Therapeutics 2019-10-11 09:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
Caliber Ophthalmics Introduces Sharpoint Edge CC3D Plus Product Line at AAO in San Francisco 2019-10-10 22:09
MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services 2019-10-10 21:00
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors 2019-10-10 15:55
Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions 2019-10-10 11:34
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million 2019-10-09 20:58
BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for Its Genomics Data Platform 2019-10-09 20:00
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial 2019-10-09 17:56
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots 2019-10-09 12:00
Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd 2019-10-09 09:42
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy 2019-10-09 07:00
1 617 618 619 620 621 962